InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Thursday, 06/14/2018 9:17:52 AM

Thursday, June 14, 2018 9:17:52 AM

Post# of 807
http://www.ocquila.com/ Oxford Biomedica, "The unambiguous world leaders in Lentiviral manufacture." Axovant CEO quote.

SIX OXB team moving to Axovant for the programme.

Re the recent FDA comments, they will be looking for accelerated pathways to approval.